Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...
Seattle’s newest unicorn: Truveta lands $320M to fuel creation of massive new genome project
The Truveta team at its Bellevue, Wash., headquarters last year. (Truveta Photo) Seattle-area health data company Truveta ...
STAT11h
The companies paying hospitals to hand over patient data to train AI
A new crop of companies is lining up to buy patient data from hospitals and sell it to those wanting to train AI or do ...
Truveta sells stakes to Regeneron, Illumina in deal to build genetic database
Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will ...
STAT2d
Pharmalittle: We’re reading about pharma asking Trump to pause Medicare talks, a Truveta database launch, and more
Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...
Modern Healthcare3d
Truveta sells $320M stake to providers, others for genome project
Seventeen health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence and ...
pharmaphorum3d
Regeneron, Illumina join $320m Truveta investment
The two companies, along with 17 US health systems, will collectively take a $320 million stake in Truveta, with Regeneron ...
FierceBiotech3d
JPM25: Regeneron, Illumina and more back Truveta for 10M genome sequencing project
Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf the efforts of ...
Seattle VC activity limps across the finish line into the new year
Fundings for Seattle-area startups lagged at the end of 2024, according to a new PitchBook-NVCA report, but they're off to a ...
Regeneron announces strategic collaboration with Truveta
Regeneron Pharmaceuticals (REGN) announced a strategic collaboration with Truveta and its collective of U.S. health systems to advance ...
Regeneron Working with Truveta's Network to Extend Database
The company said Monday that it will provide a $119.5 million investment in Truveta's Series C financing round and help launch the company's Truveta Genome Project, which will extend Regeneron's ...
Regeneron To Invest $119.5 Mln In Truveta's Financing Round, Launch Truveta Genome Project
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN), Monday announced a collaboration with software company Truveta, Inc. and its collective of U.S. healthy systems, offering a strategic investment of ...